Is concurrent LR-5 associated with a higher rate of hepatocellular carcinoma in LR-3 or LR-4 observations? An individual participant data meta-analysis
Nicole Abedrabbo,Emily Lerner,Eric Lam,Diana Kadi,Haben Dawit,Christian van der Pol,Jean-Paul Salameh,Haresh Naringrekar,Robert Adamo,Mostafa Alabousi,Brooke Levis,An Tang,Ayman Alhasan,Ashwini Arvind,Amit Singal,Brian Allen,Krzysztof Bartnik,Joanna Podgórska,Alessandro Furlan,Roberto Cannella,Marco Dioguardi Burgio,Milena Cerny,Sang Hyun Choi,Christopher Clarke,Xiang Jing,Andrea Kierans,Maxime Ronot,Grzegorz Rosiak,Hanyu Jiang,Ji Soo Song,Caecilia C Reiner,Ijin Joo,Heejin Kwon,Wentao Wang,Sheng-Xiang Rao,Federico Diaz Telli,Federico Piñero,Nieun Seo,Hyo-Jin Kang,Jin Wang,Ji Hye Min,Andreu Costa,Matthew McInnes,Mustafa Bashir
DOI: https://doi.org/10.1007/s00261-024-04580-6
2024-09-27
Abstract:Background: The Liver Imaging Reporting and Data System (LI-RADS) does not consider factors extrinsic to the observation of interest, such as concurrent LR-5 observations. Purpose: To evaluate whether the presence of a concurrent LR-5 observation is associated with a difference in the probability that LR-3 or LR-4 observations represent hepatocellular carcinoma (HCC) through an individual participant data (IPD) meta-analysis. Methods: Multiple databases were searched from 1/2014 to 2/2023 for studies evaluating the diagnostic accuracy of CT/MRI for HCC using LI-RADS v2014/2017/2018. The search strategy, study selection, and data collection process can be found at https://osf.io/rpg8x . Using a generalized linear mixed model (GLMM), IPD were pooled across studies and modeled simultaneously with a one-stage meta-analysis approach to estimate positive predictive value (PPV) of LR-3 and LR-4 observations without and with concurrent LR-5 for the diagnosis of HCC. Risk of bias was assessed using a composite reference standard and Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2). Results: Twenty-nine studies comprising 2591 observations in 1456 patients (mean age 59 years, 1083 [74%] male) were included. 587/1960 (29.9%) LR-3 observations in 1009 patients had concurrent LR-5. The PPV for LR-3 observations with concurrent LR-5 was not significantly different from the PPV without LR-5 (45.4% vs 37.1%, p = 0.63). 264/631 (41.8%) LR-4 observations in 447 patients had concurrent LR-5. The PPV for LR-4 observations with concurrent LR-5 was not significantly different from LR-4 observations without concurrent LR-5 (88.6% vs 69.5%, p = 0.08). A sensitivity analysis for low-risk of bias studies (n = 9) did not differ from the primary analysis. Conclusion: The presence of concurrent LR-5 was not significantly associated with differences in PPV for HCC in LR-3 or LR-4 observations, supporting the current LI-RADS paradigm, wherein the presence of synchronous LR-5 may not alter the categorization of LR-3 and LR-4 observations.